Search Results 821-830 of 3693 for cbd gummies

1. Publications - Barbara E. Ruddy, M.D. - Mayo Clinic

   Ruddy BE, Persons PA, Dacek ER. Breast cancer genetics and risk assessment 101: What women's health care providers need to know. Maturitas.

2. Most of the atypical antidepressants list dry mouth, dizziness or lightheadedness as possible side effects. Some antidepressants may help you sleep and are best ...

3. Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH - Mayo Clinic

   The purpose of this study is to evaluate the safety and efficacy of a single treatment of PRX302 for the treatment of Benign Prostatic Hyperplasia (BPH) as ...

4. Partnership for Early Detection of Alzheimer's Disease Using Advanced MR Technology - Mayo Clinic

   The primary objective of this application is to establish the feasibility of widespread clinical use of advanced MRS technology for early AD diagnosis in a ...

5. A Study To Investigate LP352 In Children And Adults With Developmental And Epileptic Encephalopathy (DEE) - Mayo Clinic

   About this study. This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics ...

6. Surgical Outcomes of Patients of a Single Surgeon - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine - Mayo Clinic

   This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single ...

8. American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis - Mayo Clinic

   About this study. Vasculitis is group of diseases where inflammation of blood vessels is the common feature. Patients typically present with fever, fatigue, ...

9. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as atezolizumab, may interfere ...

10. A Study to Establish a Mayo Posture Positivity Power Program (MayoP4) for Active and Aging Individuals in Communities

    The research is designed to answer effectiveness of community-based multimodal intervention programs on physical, mental, cognitive, social, and environmental ...